Fiscal 2026 Fourth Quarter Highlights (comparisons to fiscal 2025 fourth quarter)
- Total revenue increased 34.0% to a record of
$309 .0 million, driven by acquisitions during the last twelve months as well as organic growth - Contractor Solutions delivered organic revenue growth of 2.6% in the fourth quarter
- Earnings per diluted share ("EPS") of
$1.22 decreased 41.1% when compared to$2.08 , driven primarily by a non-cash impairment and higher interest expense - Adjusted EPS of
$3.14 , excluding the amortization of acquisition-related intangible assets, non-cash impairment and nonrecurring expenses, increased 21.1% when compared to$2.59 - Net income attributable to CSW of
$20 .2 million decreased 42.4% when compared to$35 .1 million - Adjusted EBITDA of
$82 .9 million increased 38.8%, setting a quarterly record - Net debt of
$842.7 million at the end of the quarter, resulting in a net leverage ratio (net Debt to EBITDA), in accordance with our credit facility, of 2.55x, within our stated target range of 1-3x
Fiscal 2026 Full Year Highlights (comparisons to fiscal 2025 full year)
- Total revenue increased 23.3% to a record of
$1 .1 billion, driven by acquisitions during the last twelve months - EPS of
$6.70 , decreased 20.0% when compared to$8.38 , driven primarily by higher interest expense, non-cash impairment, and non-recurring expenses - Adjusted EPS of
$10.38 , increased 6.9% when compared to$9.71 - Net income attributable to CSW of
$112 .0 million decreased 18.0% when compared to$136 .7 million - Adjusted EBITDA increased 18.3% to a record
$269 .6 million - Invested
$1 .0 billion in acquisitions and$17 .3 million in organic capital expenditures, while returning total cash of$145 .5 million to shareholders through share repurchases of$127 .5 million and dividends of$18 .0 million
Comments from the Chairman, President, and Chief Executive Officer
Armes continued, "Disciplined investments in immediately accretive acquisitions have added fast growing products to our portfolio, opened new end markets, and allowed CSW to leverage our broad distribution network. We enter fiscal year 2027 with a cautiously optimistic outlook for our primary end markets, and with conviction that we can continue to deliver growth that outpaces the markets we serve. We anticipate delivering meaningful growth in revenue, adjusted EBITDA, adjusted EPS, and cash flows in fiscal 2027."
Fiscal 2026 Fourth Quarter Consolidated Results
Fiscal fourth quarter revenue was
Gross profit in the fiscal fourth quarter was
Operating expenses were
Operating income in the current period was
Interest expense, net of interest income, was
In the current period, reported net income attributable to CSW decreased 42.4% to
Fiscal 2026 fourth quarter adjusted EBITDA increased 38.8% to a record
The quarterly cash flows from operations were an outflow of
Following quarter-end, the Company announced its twenty-ninth consecutive regular quarterly cash dividend in the amount of
The Company’s effective tax rate for the fiscal fourth quarter was 27.1%, or 22.0% adjusted, as compared to 24.6%, or 24.7% adjusted, in the prior year period. The lower adjusted effective tax rate in the current year period was due to the favorable impact from the finalization of annual tax provision in the fiscal fourth quarter.
Fiscal 2026 Fourth Quarter Segment Results
Contractor Solutions segment revenue was
Specialized Reliability Solutions segment revenue was
Engineered
During the fiscal quarter, in connection with the Greco Plans, we recorded a non-cash impairment charge of
Excluding the Greco businesses, Engineered
All percentages are calculated based upon the attached financial statements. Share counts used in determining the diluted EPS are based on a weighted average of outstanding shares throughout the reporting period.
Fiscal 2026 Full Year Consolidated Results
Consolidated revenue was
Gross profit in the current year was
Operating expenses as a percentage of revenue were 26.3%, or 24.0% adjusted, an increase compared to the prior year of 24.1%, or 23.6% adjusted. Adjustments to operating expenses include Greco Plans related expenses of
Operating income was
Interest expense, net was
Net income attributable to CSW decreased to
Fiscal 2026 adjusted EBITDA increased 18.3% to
Net cash provided by operating activities for fiscal 2026 was
Including cash on hand, our net debt according to our credit facility covenant calculation was
In fiscal 2026, the Company deployed
The Company’s effective tax rate for the fiscal year was 22.5%, or 24.7% adjusted, as compared to 23.7% or 25.5% adjusted in the prior year. The adjusted effective tax rate was favorably impacted by the estimated tax credits and share grant activities.
Fiscal 2026 Full Year Segment Results
Contractor Solutions segment revenue was
Specialized Reliability Solutions segment revenue grew to
Engineered
Excluding the Greco business, Engineered
All percentages are calculated based upon the attached financial statements. Share count used in determining the diluted EPS is based on a weighted average of outstanding shares throughout the measurement period.
Conference Call Information
The Company will host a conference call today at
A telephonic replay will be available shortly after the conclusion of the call and until
Safe Harbor Statement
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. Words or phrases such as "may," "should," "expects," "could," "intends," "plans," "anticipates," "estimates," "believes," "forecasts," "predicts" or other similar expressions are intended to identify forward-looking statements, which include, without limitation, earnings forecasts, effective tax rate, statements relating to our business strategy and statements of expectations, beliefs, future plans and strategies and anticipated developments concerning our industry, business, operations, and financial performance and condition.
The forward-looking statements included in this press release are based on our current expectations, projections, estimates, and assumptions. These statements are only predictions, not guarantees. Such forward-looking statements are subject to numerous risks and uncertainties that are difficult to predict. These risks and uncertainties may cause actual results to differ materially from what is forecast in such forward-looking statements, and include, without limitation, the risk factors described from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
All forward-looking statements included in this press release are based on information currently available to us, and we assume no obligation to update any forward-looking statement except as may be required by law.
Non-GAAP Financial Measures
This press release includes an analysis of adjusted diluted earnings per share attributable to CSW, adjusted net income attributable to CSW, adjusted effective tax rate, adjusted gross profit, adjusted operating expenses, adjusted operating income, adjusted operating cash flows, adjusted free cash flows, revenue calculated to include pre-acquisition revenue effect for recent acquisitions, adjusted EBS excluding Greco and adjusted CSW excluding Greco, which are non-GAAP financial measures of performance. Attributable to CSW is defined to exclude the income attributable to the non-controlling interest in the Whitmore JV.
CSW utilizes adjusted EBITDA (earnings before interest, tax, depreciation and amortization) as an additional consolidated, non-GAAP financial measure, which consists of consolidated net income including income attributable to the non-controlling interest in the Whitmore JV, adjusted to remove the impact of income taxes, interest expense, depreciation, amortization and impairment, and significant nonrecurring items.
For a reconciliation of these measures to the most directly comparable GAAP measures and for a discussion of why we consider these non-GAAP measures useful, see the “Reconciliation of Non-GAAP Measures” section of this release.
About
Investor Relations
Vice President, Investor Relations and Treasurer
214-489-7113
alexa.huerta@csw.com
CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||||
| Three Months Ended | Year Ended | |||||||||||||||
| (Amounts in thousands, except per share amounts) | 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Revenues, net | $ | 308,960 | $ | 230,549 | $ | 1,082,549 | $ | 878,301 | ||||||||
| Cost of revenues | (182,348 | ) | (128,664 | ) | (628,867 | ) | (484,989 | ) | ||||||||
| Gross profit | 126,612 | 101,885 | 453,682 | 393,312 | ||||||||||||
| Selling, general and administrative expenses | (71,445 | ) | (56,841 | ) | (269,520 | ) | (212,064 | ) | ||||||||
| Impairment expense | (15,627 | ) | — | (15,627 | ) | — | ||||||||||
| Operating income | 39,541 | 45,044 | 168,535 | 181,248 | ||||||||||||
| Interest expense, net | (11,785 | ) | 1,616 | (22,245 | ) | (269 | ) | |||||||||
| Other expense, net | 48 | (147 | ) | (737 | ) | (862 | ) | |||||||||
| Income before income taxes | 27,805 | 46,514 | 145,553 | 180,117 | ||||||||||||
| Provision for income taxes | (7,539 | ) | (11,458 | ) | (32,706 | ) | (42,633 | ) | ||||||||
| Net income | 20,264 | 35,053 | 112,847 | 137,484 | ||||||||||||
| Income attributable to redeemable noncontrolling interest | (63 | ) | 7 | (802 | ) | (832 | ) | |||||||||
| Net income attributable to CSW | $ | 20,201 | $ | 35,060 | $ | 112,045 | $ | 136,652 | ||||||||
| Net income per share attributable to CSW | ||||||||||||||||
| Basic | $ | 1.23 | $ | 2.09 | $ | 6.73 | $ | 8.41 | ||||||||
| Diluted | $ | 1.22 | $ | 2.08 | $ | 6.70 | $ | 8.38 | ||||||||
| Weighted average number of shares outstanding: | ||||||||||||||||
| Basic | 16,434 | 16,779 | 16,653 | 16,242 | ||||||||||||
| Diluted | 16,500 | 16,859 | 16,712 | 16,314 | ||||||||||||
CONSOLIDATED BALANCE SHEETS | ||||||||
| (Amounts in thousands, except per share amounts) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 33,799 | $ | 225,845 | ||||
| Accounts receivable, net | 210,264 | 155,651 | ||||||
| Inventories, net | 309,707 | 194,876 | ||||||
| Prepaid expenses and other current assets | 26,555 | 16,489 | ||||||
| Assets held for sale | 8,742 | — | ||||||
| Total current assets | 589,067 | 592,861 | ||||||
| Property, plant and equipment, net | 107,536 | 93,415 | ||||||
| 632,631 | 264,092 | |||||||
| Intangible assets, net | 900,051 | 357,910 | ||||||
| Other assets | 87,399 | 70,787 | ||||||
| Total assets | $ | 2,316,684 | $ | 1,379,065 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 76,930 | $ | 54,767 | ||||
| Accrued and other current liabilities | 116,055 | 92,435 | ||||||
| Current portion of long-term debt | 29,458 | — | ||||||
| Liabilities held for sale | 4,478 | — | ||||||
| Total current liabilities | 226,921 | 147,202 | ||||||
| Long-term debt | 839,836 | — | ||||||
| Retirement benefits payable | 1,040 | 1,083 | ||||||
| Other long-term liabilities | 179,489 | 138,347 | ||||||
| Noncurrent liabilities, discontinued operations | — | — | ||||||
| Total liabilities | 1,247,286 | 286,632 | ||||||
| Commitments and contingencies (Note 18) | ||||||||
| Redeemable noncontrolling interest | 18,989 | 20,187 | ||||||
| Equity: | ||||||||
| Common shares, | 178 | 177 | ||||||
| Additional paid-in capital | 520,076 | 501,286 | ||||||
| (257,704 | ) | (122,125 | ) | |||||
| Retained earnings | 798,956 | 705,035 | ||||||
| Accumulated other comprehensive loss | (11,097 | ) | (12,127 | ) | ||||
| Total equity | 1,050,409 | 1,072,246 | ||||||
| Total liabilities and equity | $ | 2,316,684 | $ | 1,379,065 | ||||
CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
| Year Ended | ||||||||
| (Amounts in thousands) | 2026 | 2025 | ||||||
| Cash flows from operating activities: | ||||||||
| Net income | $ | 112,847 | $ | 137,484 | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation | 15,907 | 14,210 | ||||||
| Amortization of acquisition-related intangible assets & inventory step- | 51,174 | 28,029 | ||||||
| Amortization of deferred financing fees | 1,071 | 766 | ||||||
| Provision for inventory reserves | 4,254 | 2,686 | ||||||
| Provision for credit losses | 2,279 | 1,408 | ||||||
| Share-based and other executive compensation | 14,930 | 13,587 | ||||||
| Fair value change in contingent consideration | — | 2100 | ||||||
| Net loss (gain) on disposals of property, plant and equipment | 756 | 35 | ||||||
| Net pension benefit | 67 | 66 | ||||||
| Impairment expenses | 15,634 | — | ||||||
| Net deferred taxes | (6,035 | ) | (6,915 | ) | ||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (27,076 | ) | (9,116 | ) | ||||
| Inventories | (36,751 | ) | (35,699 | ) | ||||
| Prepaid expenses and other current assets | (5,204 | ) | (1,369 | ) | ||||
| Other assets | 782 | 1,424 | ||||||
| Accounts payable and other current liabilities | 10,702 | 21,664 | ||||||
| Retirement benefits payable and other liabilities | (5,684 | ) | (1,998 | ) | ||||
| Net cash provided by operating activities | 149,653 | 168,362 | ||||||
| Cash flows from investing activities: | ||||||||
| Capital expenditures | (17,257 | ) | (16,266 | ) | ||||
| Proceeds from sale of assets | 217 | 1,229 | ||||||
| Cash paid for investments | (4,800 | ) | (2,500 | ) | ||||
| Cash paid for acquisitions (net of cash received) | (1,021,233 | ) | (84,684 | ) | ||||
| Net cash used in investing activities | (1,043,073 | ) | (102,221 | ) | ||||
| Cash flows from financing activities: | ||||||||
| Borrowings on lines of credit | 505,724 | 32,723 | ||||||
| Repayments of lines of credit | (226,724 | ) | (198,723 | ) | ||||
| Borrowings on Term Loan A | 600,000 | — | ||||||
| Repayments on Term Loan A | (7,500 | ) | — | |||||
| Payments of deferred loan costs | (5,271 | ) | — | |||||
| Payments of contingent consideration | (11,988 | ) | (1,085 | ) | ||||
| Purchase of treasury shares | (132,746 | ) | (27,693 | ) | ||||
| Proceeds from issuance of equity | — | 347,407 | ||||||
| Distributions to redeemable noncontrolling interest shareholder | (2,000 | ) | — | |||||
| Dividends paid to shareholders | (18,021 | ) | (14,582 | ) | ||||
| Net cash provided by (used in) provided by financing activities | 701,474 | 138,047 | ||||||
| Effect of exchange rate changes on cash and equivalents | (100 | ) | (499 | ) | ||||
| Net change in cash and cash equivalents | (192,046 | ) | 203,689 | |||||
| Cash and cash equivalents, beginning of period | 225,845 | 22,156 | ||||||
| Cash and cash equivalents, end of period | $ | 33,799 | $ | 225,845 | ||||
Reconciliation of Non-GAAP Measures
We use adjusted earnings per share attributable to CSW, adjusted net income attributable to CSW, adjusted gross profit, adjusted operating expenses, adjusted operating income, adjusted effective tax rate, adjusted EBITDA, adjusted operating cash flows, free cash flows, revenue calculated to include pre-acquisition revenue effect for recent acquisitions, adjusted EBS excluding Greco and adjusted CSW excluding Greco, together with financial measures prepared in accordance with GAAP, such as revenue, cost of revenue, operating expense, operating income, net income attributable to CSW and operating cash flows, to assess our historical and prospective operating performance and to enhance our understanding of our core operating performance. Free cash flow is a non-GAAP financial measure and is defined as cash flow from operations less capital expenditures. We believe these measures are useful for investors to assess the operating performance of our business without the effect of non-recurring items. In the following tables, there could be immaterial differences in amounts presented due to rounding.
| Reconciliation of Net Income Attributable to CSW to Adjusted Net Income Attributable to CSW | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| (Amounts in thousands) | Three Months Ended | Year Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Net income attributable to CSW | $ | 20,202 | $ | 35,061 | $ | 112,045 | $ | 136,652 | ||||||||
| Adjusting items: | ||||||||||||||||
| Amortization of acquisition-related intangible assets and inventory step-up | 16,198 | 7,833 | 51,173 | 28,014 | ||||||||||||
| Amortization tax effect | (4,075 | ) | (1,874 | ) | (12,727 | ) | (6,866 | ) | ||||||||
| Acquisition-related integration expenses, net of tax effect | 2,679 | — | 5,773 | — | ||||||||||||
| Nonrecurring inventory write down, net of tax effect | 865 | — | 2,361 | — | ||||||||||||
| Acquisition-related transaction expenses, net of tax effect | 283 | 1,074 | 3,829 | 1,716 | ||||||||||||
| Greco | 1,575 | — | 1,575 | — | ||||||||||||
| Nonrecurring restructuring expenses, net of tax effect | 408 | — | 408 | — | ||||||||||||
| Greco impairment expenses, net of tax effect | 13,617 | — | 13,617 | — | ||||||||||||
| Uncertain tax position accrual release | — | — | (4,544 | ) | (2,691 | ) | ||||||||||
| Fair value change in contingent consideration, net of tax effect | — | 1,573 | — | 1,573 | ||||||||||||
| Adjusted net income attributable to CSW | $ | 51,752 | $ | 43,666 | $ | 173,510 | $ | 158,398 | ||||||||
| Net Income Attributable to CSW per diluted common share | $ | 1.22 | $ | 2.08 | $ | 6.70 | $ | 8.38 | ||||||||
| Adjusting Items, per dilutive common share: | ||||||||||||||||
| Amortization of acquisition-related intangible assets and inventory step-up | 0.98 | 0.46 | 3.06 | 1.72 | ||||||||||||
| Amortization tax effect | (0.25 | ) | (0.11 | ) | (0.76 | ) | (0.42 | ) | ||||||||
| Acquisition-related integration expenses, net of tax effect | 0.16 | — | 0.35 | — | ||||||||||||
| Nonrecurring inventory write down, net of tax effect | 0.05 | — | 0.14 | — | ||||||||||||
| Acquisition-related transaction expenses, net of tax effect | 0.02 | 0.06 | 0.23 | 0.11 | ||||||||||||
| Greco | 0.10 | — | 0.09 | — | ||||||||||||
| Nonrecurring restructuring expenses, net of tax effect | 0.02 | — | 0.02 | — | ||||||||||||
| Greco impairment expenses, net of tax effect | 0.83 | — | 0.81 | — | ||||||||||||
| Uncertain tax position accrual release | — | — | (0.27 | ) | (0.16 | ) | ||||||||||
| Fair value change in contingent consideration, net of tax effect | — | 0.09 | — | 0.10 | ||||||||||||
| Adjusted net income attributable to CSW per dilutive common share | $ | 3.14 | $ | 2.59 | $ | 10.38 | $ | 9.71 | ||||||||
| Reconciliation of Effective Tax Rate to Adjusted Effective Tax Rate | ||||||||||||||||
| (unaudited) | ||||||||||||||||
| (Amounts in thousands) | Three Months Ended | Year Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| GAAP income before tax | $ | 27,804 | $ | 46,513 | $ | 145,553 | $ | 180,117 | ||||||||
| Adjusting items: | ||||||||||||||||
| Acquisition-related integration expenses | 3,501 | — | 7,664 | — | ||||||||||||
| Nonrecurring inventory write down | 1,083 | — | 3,135 | — | ||||||||||||
| Acquisition-related transaction expenses | 170 | 1,434 | 4,265 | 2,294 | ||||||||||||
| Nonrecurring restructuring expenses | 542 | — | 542 | — | ||||||||||||
| Greco Canada Exit related expenses | 2,130 | — | 2,130 | — | ||||||||||||
| Greco impairment expenses | 15,627 | — | 15,627 | — | ||||||||||||
| Fair value change in contingent consideration liability | — | 2,100 | — | 2,100 | ||||||||||||
| Reversal of tax indemnification receivable | — | — | 1,406 | 858 | ||||||||||||
| Adjusted income before tax | $ | 50,857 | $ | 50,046 | $ | 180,322 | $ | 185,369 | ||||||||
| GAAP provision for income tax | $ | 7,539 | $ | 11,458 | $ | 32,706 | $ | 42,633 | ||||||||
| Adjusting items: | ||||||||||||||||
| Tax effect of acquisition-related integration expenses | 822 | — | 1,891 | — | ||||||||||||
| Tax effect of nonrecurring inventory write down | 218 | — | 774 | — | ||||||||||||
| Tax effect of acquisition-related transaction expenses | (113 | ) | 360 | 436 | 578 | |||||||||||
| Tax effect of nonrecurring restructuring expenses | 134 | — | 134 | — | ||||||||||||
| Tax effect of Greco Canada Exit related expenses | 555 | — | 555 | — | ||||||||||||
| Tax effect of Greco impairment expenses | 2,010 | — | 2,010 | — | ||||||||||||
| Tax effect of fair value change in contingent consideration liability | — | 527 | — | 527 | ||||||||||||
| Tax effect of reversal of tax indemnification receivable | — | — | 1,406 | 858 | ||||||||||||
| Uncertain tax position accrual release | — | — | 4,544 | 2,691 | ||||||||||||
| Adjusted provision for income tax | $ | 11,165 | $ | 12,345 | $ | 44,456 | $ | 47,287 | ||||||||
| GAAP effective tax rate | 27.1 | % | 24.6 | % | 22.5 | % | 23.7 | % | ||||||||
| Adjusted effective tax rate | 22.0 | % | 24.7 | % | 24.7 | % | 25.5 | % | ||||||||
| Reconciliation of Contractor Solutions Segment Reported Revenue to Revenue Calculated to Include Pre-Acquisition Revenue Effect | |||||||
| (unaudited) | |||||||
| (Amounts in thousands) | Three Months Ended | ||||||
| 2026 | 2025 | ||||||
| Contractor Solutions Segment Reported Revenue, Net | $ | 237,110 | $ | 165,929 | |||
| Adjusting Items: | |||||||
| Pre-acquisition revenue effect for recent acquisitions (a) | — | 58,797 | |||||
| $ | 237,110 | $ | 224,726 | ||||
| (a) Revenue effect from MARS Parts and Aspen Manufacturing acquisitions as if the acquisitions had been owned by CSW during the same months in the quarter ended | |||||||
| Reconciliation of Net Income Attributable to CSW to Adjusted EBITDA | ||||||||||||||||
| (unaudited) | ||||||||||||||||
| (Amounts in thousands) | Three Months Ended | Year Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Net Income attributable to CSW | $ | 20,202 | $ | 35,061 | $ | 112,045 | $ | 136,652 | ||||||||
| Plus: Income attributable to redeemable noncontrolling interest | 63 | (7 | ) | 802 | 832 | |||||||||||
| Net Income | $ | 20,265 | $ | 35,054 | $ | 112,846 | $ | 137,484 | ||||||||
| Adjusting Items: | ||||||||||||||||
| Interest expense, net | 11,785 | (1,616 | ) | 22,245 | 269 | |||||||||||
| Income tax expense | 7,539 | 11,458 | 32,706 | 42,633 | ||||||||||||
| Depreciation & amortization | 20,284 | 11,327 | 67,071 | 42,223 | ||||||||||||
| Greco impairment expense | 15,627 | — | 15,627 | — | ||||||||||||
| EBITDA | $ | 75,500 | $ | 56,224 | $ | 250,496 | $ | 222,608 | ||||||||
| EBITDA Adjustments: | ||||||||||||||||
| Acquisition-related integration expenses | 3,501 | — | 7,664 | — | ||||||||||||
| Nonrecurring inventory write down | 1,083 | — | 3,135 | — | ||||||||||||
| Acquisition-related transaction expenses | 170 | 1,434 | 4,265 | 2,294 | ||||||||||||
| Nonrecurring restructuring expenses | 542 | — | 542 | — | ||||||||||||
| Greco | 2,130 | — | 2,130 | — | ||||||||||||
| Fair value change in contingent consideration | — | 2,100 | 2,100 | |||||||||||||
| Reversal of tax indemnification receivable | — | — | 1,406 | 858 | ||||||||||||
| Adjusted EBITDA | $ | 82,926 | $ | 59,758 | $ | 269,638 | $ | 227,860 | ||||||||
| Adjusted EBITDA % Revenue | 26.8 | % | 25.9 | % | 24.9 | % | 25.9 | % | ||||||||
| Reconciliation of Gross Profit to Adjusted Gross Profit | ||||||||||||||||
| (unaudited) | ||||||||||||||||
| (Amounts in thousands) | Three months ended | Year Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Gross Profit | $ | 126,612 | $ | 101,885 | $ | 453,682 | $ | 393,312 | ||||||||
| Gross Profit % Revenue | 41.0 | % | 44.2 | % | 41.9 | % | 44.8 | % | ||||||||
| Adjusting Items: | ||||||||||||||||
| Acquisition-related integration expenses | 1,572 | — | 4,017 | — | ||||||||||||
| Nonrecurring inventory write down | 1,083 | — | 3,135 | — | ||||||||||||
| Greco | 739 | — | 739 | — | ||||||||||||
| Nonrecurring COGS reclass | 4,497 | — | — | — | ||||||||||||
| Adjusted Gross Profit | $ | 134,503 | $ | 101,885 | $ | 461,573 | $ | 393,312 | ||||||||
| Adjusted Gross Profit % Revenue | 43.5 | % | 44.2 | % | 42.6 | % | 44.8 | % | ||||||||
| Reconciliation of Operating Expenses to Adjusted Operating Expenses | ||||||||||||||||
| (unaudited) | ||||||||||||||||
| (Amounts in thousands) | Three months ended | Year Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Operating expenses (a) | $ | 87,072 | $ | 56,841 | $ | 285,147 | $ | 212,065 | ||||||||
| Operating expenses % Revenue | 28.2 | % | 24.7 | % | 26.3 | % | 24.1 | % | ||||||||
| Adjusting Items: | ||||||||||||||||
| Acquisition-related integration expenses | (1,929 | ) | — | (3,650 | ) | — | ||||||||||
| Acquisition-related transaction expenses | (170 | ) | (1,434 | ) | (4,265 | ) | (2,294 | ) | ||||||||
| Greco | (1,391 | ) | — | (1,391 | ) | — | ||||||||||
| Nonrecurring restructuring expenses | (542 | ) | — | (542 | ) | — | ||||||||||
| Greco impairment expenses | (15,627 | ) | — | (15,627 | ) | — | ||||||||||
| Fair value change in contingent consideration | — | (2,100 | ) | — | (2,100 | ) | ||||||||||
| Nonrecurring COGS reclass | 4,497 | — | — | — | ||||||||||||
| Adjusted Operating expenses | $ | 71,909 | $ | 53,307 | $ | 259,673 | $ | 207,671 | ||||||||
| Adjusted Operating expenses % Revenue | 23.3 | % | 23.1 | % | 24.0 | % | 23.6 | % | ||||||||
(a) Operating expenses include selling, general, and administrative expense and impairment expense.
| Reconciliation of Segment Operating Income to Segment Adjusted EBITDA | |||||||||||||||
| (unaudited) | |||||||||||||||
| (Amounts in thousands) | Three Months Ended | ||||||||||||||
| Contractor Solutions | Specialized Reliability Solutions | Engineered Building Solutions | Corporate and Other | Consolidated | |||||||||||
| Revenue, net | $ | 237,110 | $ | 46,216 | $ | 27,650 | $ | (2,015 | ) | $ | 308,960 | ||||
| Operating Income | $ | 52,753 | $ | 7,228 | $ | (13,373 | ) | $ | (7,068 | ) | $ | 39,541 | |||
| % Revenue | 22.2 | % | 15.6 | % | (48.4) % | 12.8 | % | ||||||||
| Adjusting Items: | |||||||||||||||
| Acquisition-related integration expenses | 2,842 | 660 | — | — | 3,502 | ||||||||||
| Nonrecurring inventory write down | 1,083 | — | — | — | 1,083 | ||||||||||
| Acquisition-related transaction expenses | 170 | — | — | — | 170 | ||||||||||
| Nonrecurring restructuring expenses | — | 542 | — | — | 542 | ||||||||||
| Greco | — | — | 2,130 | — | 2,130 | ||||||||||
| Greco impairment expenses | — | — | 15,627 | — | 15,627 | ||||||||||
| Adjusted Operating Income | $ | 56,848 | $ | 8,430 | $ | 4,385 | $ | (7,068 | ) | $ | 62,595 | ||||
| % Revenue | 24.0 | % | 18.2 | % | 15.9 | % | 20.3 | % | |||||||
| Adjusting Items: | |||||||||||||||
| Other income (expense), net | 109 | (2 | ) | (7 | ) | (52 | ) | 48 | |||||||
| Depreciation & amortization | 18,145 | 1,625 | 487 | 26 | 20,284 | ||||||||||
| Adjusted EBITDA | $ | 75,103 | $ | 10,052 | $ | 4,865 | $ | (7,093 | ) | $ | 82,927 | ||||
| % Revenue | 31.7 | % | 21.8 | % | 17.6 | % | 26.8 | % | |||||||
| (Amounts in thousands) | Three Months Ended | ||||||||||||||
| Contractor Solutions | Specialized Reliability Solutions | Engineered Building Solutions | Corporate and Other | Consolidated | |||||||||||
| Revenue, net | $ | 165,929 | $ | 37,750 | $ | 28,732 | $ | (1,861 | ) | $ | 230,549 | ||||
| Operating Income | $ | 42,999 | $ | 4,465 | $ | 3,736 | $ | (6,156 | ) | $ | 45,044 | ||||
| % Revenue | 25.9 | % | 11.8 | % | 13.0 | % | 19.5 | % | |||||||
| Adjusting Items: | |||||||||||||||
| Fair value change in contingent consideration liability | 2,100 | — | — | — | 2,100 | ||||||||||
| Acquisition-related transaction expenses | 1,434 | — | — | — | 1,434 | ||||||||||
| Adjusted Operating Income | $ | 46,533 | $ | 4,465 | $ | 3,736 | $ | (6,156 | ) | $ | 48,577 | ||||
| % Revenue | 28.0 | % | 11.8 | % | 13.0 | % | 21.1 | % | |||||||
| Adjusting Items: | |||||||||||||||
| Other income (expense), net | (36 | ) | (34 | ) | (12 | ) | (65 | ) | (147 | ) | |||||
| Depreciation and amortization | 9,502 | 1,356 | 427 | 42 | 11,327 | ||||||||||
| Adjusted EBITDA | $ | 55,998 | $ | 5,787 | $ | 4,152 | $ | (6,179 | ) | $ | 59,758 | ||||
| % Revenue | 33.7 | % | 15.3 | % | 14.5 | % | 25.9 | % | |||||||
| Reconciliation of Segment Operating Income to Segment Adjusted EBITDA | |||||||||||||||
| (unaudited) | |||||||||||||||
| (Amounts in thousands) | Year Ended | ||||||||||||||
| Contractor Solutions | Specialized Reliability Solutions | Engineered Building Solutions | Corporate and Other | Consolidated | |||||||||||
| Revenue, net | $ | 810,317 | $ | 160,111 | $ | 119,911 | $ | (7,789 | ) | $ | 1,082,549 | ||||
| Operating Income | $ | 175,677 | $ | 22,079 | $ | (1,180 | ) | $ | (28,042 | ) | $ | 168,535 | |||
| % Revenue | 21.7 | % | 13.8 | % | (1.0)% | 15.6 | % | ||||||||
| Adjusting Items: | |||||||||||||||
| Acquisition-related integration expenses | 6,617 | 1,047 | — | — | 7,664 | ||||||||||
| Nonrecurring inventory write down | 3,135 | — | — | — | 3,135 | ||||||||||
| Acquisition-related transaction expenses | 2,862 | 423 | — | 979 | 4,265 | ||||||||||
| Nonrecurring restructuring expenses | — | 542 | — | — | 542 | ||||||||||
| Greco | — | — | 2,130 | — | 2,130 | ||||||||||
| Greco impairment expenses | — | — | 15,627 | — | 15,627 | ||||||||||
| Adjusted Operating Income | $ | 188,291 | $ | 24,092 | $ | 16,578 | $ | (27,063 | ) | $ | 201,898 | ||||
| % Revenue | 23.2 | % | 15.0 | % | 13.8 | % | 18.7 | % | |||||||
| Adjusting Items: | |||||||||||||||
| Other income (expense), net | (343 | ) | (136 | ) | 8 | (266 | ) | (737 | ) | ||||||
| Depreciation & amortization | 59,408 | 5,725 | 1,827 | 112 | 67,071 | ||||||||||
| Reversal of tax indemnification receivable | 1,406 | — | — | — | 1,406 | ||||||||||
| Adjusted EBITDA | $ | 248,762 | $ | 29,681 | $ | 18,412 | $ | (27,217 | ) | $ | 269,639 | ||||
| % Revenue | 30.7 | % | 18.5 | % | 15.4 | % | 24.9 | % | |||||||
| (Amounts in thousands) | Year Ended | ||||||||||||||
| Contractor Solutions | Specialized Reliability Solutions | Engineered Building Solutions | Corporate and Other | Consolidated | |||||||||||
| Revenue, net | $ | 617,331 | $ | 147,641 | $ | 121,119 | $ | (7,791 | ) | $ | 878,301 | ||||
| Operating Income | $ | 165,893 | $ | 22,673 | $ | 19,187 | $ | (26,505 | ) | $ | 181,248 | ||||
| % Revenue | 26.9 | % | 15.4 | % | 15.8 | % | 20.6 | % | |||||||
| Adjusting Items: | |||||||||||||||
| Fair value change in contingent consideration liability | 2,100 | — | — | — | 2,100 | ||||||||||
| Acquisition-related transaction expenses | 2,294 | — | — | — | 2,294 | ||||||||||
| Adjusted Operating Income | $ | 170,287 | $ | 22,673 | $ | 19,187 | $ | (26,505 | ) | $ | 185,641 | ||||
| % Revenue | 27.6 | % | 15.4 | % | 15.8 | % | 21.1 | % | |||||||
| Adjusting Items: | |||||||||||||||
| Other income (expense), net | (371 | ) | (233 | ) | 7 | (265 | ) | (862 | ) | ||||||
| Depreciation & amortization | 34,666 | 5,553 | 1,826 | 177 | 42,223 | ||||||||||
| Reversal of tax indemnification receivable | 858 | — | — | — | 858 | ||||||||||
| Adjusted EBITDA | $ | 205,440 | $ | 27,993 | $ | 21,020 | $ | (26,593 | ) | $ | 227,860 | ||||
| % Revenue | 33.3 | % | 19.0 | % | 17.4 | % | 25.9 | % | |||||||
| Reconciliation of Operating Cash Flow to Free Cash Flow | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| (Amounts in thousands) | Three Months Ended | Year Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Net cash (used in) provided by operating activities | $ | (1,682 | ) | $ | 27,293 | $ | 149,653 | $ | 168,362 | |||||||
| Less: Capital expenditures | (5,127 | ) | (4,531 | ) | (17,257 | ) | (16,266 | ) | ||||||||
| Free cash flow | $ | (6,809 | ) | $ | 22,762 | $ | 132,396 | $ | 152,096 | |||||||
| Adjusted EBITDA | $ | 82,927 | $ | 59,758 | $ | 269,639 | $ | 227,860 | ||||||||
| Free cash flow % Adj. EBITDA | (8.2)% | 38.1 | % | 49.1 | % | 66.7 | % | |||||||||
| Reconciliation of Adjusted CSW to Adjusted CSW excluding Greco | |||||||||||||||||||
| (Unaudited) | |||||||||||||||||||
| (Amounts in thousands) | Three months ended | ||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||
| CSW Consolidated | Greco Consolidated | CSW Consolidated excluding Greco | CSW Consolidated | Greco Consolidated | CSW Consolidated excluding Greco | ||||||||||||||
| Revenues, net | $ | 308,960 | $ | 5,903 | $ | 303,057 | $ | 230,549 | $ | 9,058 | $ | 221,491 | |||||||
| Adjusted EBITDA | 82,927 | (751 | ) | 83,678 | 59,758 | (25 | ) | 59,783 | |||||||||||
| Adjusted EBITDA Margin | 26.8 | % | (12.7)% | 27.6 | % | 25.9 | % | (0.3)% | 27.0 | % | |||||||||
| Amortization Adjusted EPS | $ | 3.14 | $ | (0.05 | ) | $ | 3.19 | $ | 2.59 | $ | (0.01 | ) | $ | 2.61 | |||||
| Year Ended | |||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||
| CSW Consolidated | Greco Consolidated | CSW Consolidated excluding Greco | CSW Consolidated | Greco Consolidated | CSW Consolidated excluding Greco | ||||||||||||||
| Revenues, net | $ | 1,082,549 | $ | 33,450 | $ | 1,049,100 | $ | 878,301 | $ | 39,529 | $ | 838,771 | |||||||
| Adjusted EBITDA | 269,638 | (407 | ) | 270,045 | 227,860 | 3,950 | 223,910 | ||||||||||||
| Adjusted EBITDA Margin | 24.9 | % | (1.2)% | 25.7 | % | 25.9 | % | 10.0 | % | 26.7 | % | ||||||||
| Amortization Adjusted EPS | $ | 10.38 | $ | (0.08 | ) | $ | 10.46 | $ | 9.71 | $ | 0.12 | $ | 9.59 | ||||||
| Reconciliation of Adjusted EBS to Adjusted EBS excluding Greco | |||||||||||||||||||
| (Unaudited) | |||||||||||||||||||
| (Amounts in thousands) | Three months ended | ||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||
| EBS | Greco Consolidated | EBS, excluding Greco | EBS | Greco Consolidated | EBS, excluding Greco | ||||||||||||||
| Revenues, net | $ | 27,650 | $ | 5,903 | $ | 21,746 | $ | 28,732 | $ | 9,058 | $ | 19,674 | |||||||
| Adjusted EBITDA | 4,865 | (751 | ) | 5,616 | 4,152 | (25 | ) | 4,177 | |||||||||||
| Adjusted EBITDA Margin | 17.6 | % | (12.7)% | 25.8 | % | 14.5 | % | (0.3)% | 21.2 | % | |||||||||
| Year Ended | |||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||
| EBS | Greco Consolidated | EBS, excluding Greco | EBS | Greco Consolidated | EBS, excluding Greco | ||||||||||||||
| Revenues, net | $ | 119,911 | $ | 33,450 | $ | 86,462 | $ | 121,119 | $ | 39,529 | $ | 81,590 | |||||||
| Adjusted EBITDA | 18,412 | (407 | ) | 18,819 | 21,020 | 3,950 | 17,070 | ||||||||||||
| Adjusted EBITDA Margin | 15.4 | % | (1.2)% | 21.8 | % | 17.4 | % | 10.0 | % | 20.9 | % | ||||||||
| Net Debt to Adjusted EBITDA Ratio per Revolving Credit Facility ("RCF") | ||||
| (Unaudited) | ||||
| (in thousands, except net debt to adjusted EBITDA ratio) | ||||
| GAAP debt | $ | 871,500 | ||
| Minus: GAAP cash | (33,799 | ) | ||
| Add: Restricted cash per RCF | 4,628 | |||
| Add: Capital lease liabilities | 330 | |||
| Net debt per RCF | $ | 842,659 | ||
| GAAP Net Income | $ | 112,846 | ||
| Interest expense, net | 22,245 | |||
| Income tax expense | 32,706 | |||
| Depreciation & amortization | 67,071 | |||
| Greco impairment expense | 15,627 | |||
| Proforma EBITDA for acquisitions | 44,675 | |||
| Stock compensation expenses | 14,930 | |||
| Acquisition transaction and integration expenses | 12,675 | |||
| Prior year ESOP contribution | 4,859 | |||
| Greco Canada Exit related expenses | 2,130 | |||
| Non-cash tax indemnification expense | 1,406 | |||
| Nonrecurring restructuring expenses | 542 | |||
| Other misc. adjustments per RCF | (850 | ) | ||
| Adjusted EBITDA per RCF | $ | 330,863 | ||
| Net debt to adjusted EBITDA ratio per RCF | 2.55x | |||
Source: